Global Health Ltd Approves Grant of 10,000 ESOPs Under LTIP 2024 Plan
Global Health Limited (GHL) announced that its Nomination and Remuneration Committee approved the grant of 10,000 ESOPs (Employee Stock Options) on May 11, 2026. The grant falls under Part-A of the company's GHL Employee Long Term Share Based Incentive Plan 2024 (GHL LTIP 2024 Plan).The approval details the allocation of options to a single employee, utilizing the GHL Employees Stock Option Scheme, 2024.
The ESOS 2024 was established to reward employees for their association, dedication, and contribution to the company's goals. GHL views the ESOS as a long-term incentive tool designed to attract, retain, and motivate key talent, encouraging employees to become co-owners and contribute to overall corporate growth and profitability.
Key Details of the ESOP Grant
The options are subject to specific terms and conditions, as outlined by the company.| Particulars | Details |
|---|---|
| Scheme Name | Global Health Limited Employees Long Term Share Based Incentive Plan - 2024 |
| Total Options Granted | 10,000 Stock options |
| Recipient Count | One employee |
| Exercise Price (per option) | Rs. 960/- |
| Equity Share Price | Rs. 2/- each |
| Vestment Period | Options granted under the current tranche would vest in accordance with the Vesting schedule and Vesting Conditions, subject to a maximum period of 5 years from the date of grant. |
| Exercise Window | The vested Options must be exercised within a maximum period of 3 years from the date of vesting of the last installment of Options under the GHL LTIP 2024 Plan. |
| Compliance | The GHL LTIP 2024 is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. |
MEDANTA Stock Price Movement
Shares of Global Health Limited are edging higher to ₹1215.3 as of 12:24 PM today, rallying 1.22% in live trading with an absolute gain of ₹14.70. The stock shows robust activity so far in the session, trading on a volume of 63,004 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.